首页> 美国卫生研究院文献>Wiley-Blackwell Online Open >Comparison of an AC‐taxane versus AC‐free regimen and paclitaxel versus docetaxel in patients with lymph node‐positive breast cancer: Final results of the National Surgical Adjuvant Study of Breast Cancer 02 trial a randomized comparative phase 3 study

【2h】

Comparison of an AC‐taxane versus AC‐free regimen and paclitaxel versus docetaxel in patients with lymph node‐positive breast cancer: Final results of the National Surgical Adjuvant Study of Breast Cancer 02 trial a randomized comparative phase 3 study

机译：淋巴结阳性乳腺癌患者中AC-紫杉烷与AC非方案紫杉醇与多西他赛的比较：美国国家乳腺癌外科辅助研究02试验的最终结果（一项随机比较的3期研究）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BACKGROUNDIn postoperative patients with breast cancer, the combination of an anthracycline and cyclophosphamide (AC) followed by a taxane is a standard regimen. In the current study, the authors examined whether AC could be safely omitted, and compared the effectiveness of paclitaxel versus docetaxel.

机译：背景技术在乳腺癌术后患者中，蒽环类和环磷酰胺（AC）联合紫杉烷的联合治疗是标准方案。在当前的研究中，作者检查了是否可以安全地省略AC，并比较了紫杉醇和多西他赛的有效性。

著录项

期刊名称 Wiley-Blackwell Online Open
作者
Toru Watanabe; Masaru Kuranami; Kenichi Inoue; Norikazu Masuda; Kenjiro Aogi; Shinji Ohno; Hiroji Iwata; Hirofumi Mukai; Yukari Uemura; Yasuo Ohashi;
展开▼
作者单位

展开▼
年(卷),期 -1(123),5
年度 -1
页码 759–768
总页数 10
原文格式 PDF
正文语种
中图分类
关键词
adjuvant therapy docetaxel doxorubicin and cyclophosphamide (AC)‐taxane paclitaxel randomized phase 3;

机译：辅助治疗;多西他赛;阿霉素和环磷酰胺（AC）-紫杉烷;紫杉醇;随机分期3;

相似文献

外文文献
中文文献
专利

1. Comparison of an AC-Taxane Versus AC-Free Regimen and Paclitaxel Versus Docetaxel in Patients With Lymph Node-Positive Breast Cancer: Final Results of the National Surgical Adjuvant Study of Breast Cancer O 2 Trial, a Randomized Comparative Phase 3 Study [J] . Watanabe Toru, Kuranami Masaru, Inoue Kenichi, Cancer: A Journal of the American Cancer Society . 2017,第5期

机译：对患有淋巴结阳性乳腺癌患者的AC-紫杉烷与无型无亚紫外线和紫杉醇的比较：国家外科乳腺癌患者的最终结果O 2试验，一种随机对比第3期研究
2. Subjective and objective assessment of edema during adjuvant chemotherapy for breast cancer using taxane-containing regimens in a randomized controlled trial: The national surgical adjuvant study of breast cancer 02 [J] . OhsumiS., ShimozumaK., OhashiY., Oncology: International Journal of Cancer Research and Treatment . 2012,第3期

机译：在一项随机对照试验中，使用含紫杉烷的方案对乳腺癌辅助化疗期间的水肿进行主观和客观评估：乳腺癌国家手术辅助研究02
3. Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evaluation (FACE) Trial (vol 35, pg 1041, 2017) [J] . Burris Howard A. Journal of Clinical Oncology . 2019,第4期

机译：佐剂Letrozole对蛋白质受体患者阳性阳性阳性，节点阳性早期乳腺癌患者的比较疗效和安全性：随机阶段III女性的最终结果与Anstrozole临床评价（Face）试验（Vol 35，PG 1041,2017）
4. A co-axial projection surgical navigation system for breast cancer sentinel lymph node mapping: system design and clinical trial [C] . Peng Liu, Pengfei Shao, Jianmin Ma, Advanced Biomedical and Clinical Diagnostic and Surgical Guidance Systems XVII . 2019

机译：乳腺癌前哨淋巴结定位的同轴投影手术导航系统：系统设计和临床试验
5. Evaluation of pathologic parameters and published nomograms in predicting non-sentinel lymph node metastases in female breast cancer patients with positive sentinel lymph nodes. [D] . Murch, Lisa Elaine. 2007

机译：在前哨淋巴结阳性的女性乳腺癌患者中预测非前哨淋巴结转移的病理参数和公布的列线图评估。
6. Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive early breast cancer patients: the SOLE randomised phase 3 trial [O] . Karin Ribi, Weixiu Luo, Marco Colleoni, 2020

机译：纠正：早期淋巴结阳性早期乳腺癌患者长期连续或间歇使用来曲唑辅助治疗的生活质量：SOLE随机3期试验
7. Comparison of an AC‐taxane versus AC‐free regimen and paclitaxel versus docetaxel in patients with lymph node‐positive breast cancer: Final results of the National Surgical Adjuvant Study of Breast Cancer 02 trial, a randomized comparative phase 3 study [O] . Toru Watanabe, Masaru Kuranami, Kenichi Inoue, 2017

机译：对患有淋巴结阳性乳腺癌患者的AC-紫杉烷与无缺陷症患者的比较与无亚紫杉醇与多西紫杉醇：乳腺癌02审判的国家外科辅助研究的最终结果，随机对比第3期研究

Comparison of an AC‐taxane versus AC‐free regimen and paclitaxel versus docetaxel in patients with lymph node‐positive breast cancer: Final results of the National Surgical Adjuvant Study of Breast Cancer 02 trial a randomized comparative phase 3 study

摘要

著录项

相似文献

相关主题

期刊订阅